Healthy Subjects Clinical Trial
— SAPOVerified date | May 2017 |
Source | University of Copenhagen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Cooking meat at low temperatures for prolonged times is widely used among chefs and in food
service due to the possibility to obtain a consistent and appealing eating quality. The
method is generally termed low-temperature long-time (LTLT) cooking. In LTLT cooking, meat
is vacuum-packed and heated at temperatures between 50°C and 65°C in a water bath for
several hours. LTLT has several benefits - improved tenderness and juiciness, less cooking
loss, better vitamin retention and uncompromised food safety.
A recent PhD thesis concluded that one of the mechanisms behind the changes in eating
quality during LTLT cooking was due to the proteolytic degradation in the muscle tissue. The
activity of proteolytic enzymes has shown to be dependent on heating temperature and time
where the cathepsins were found to remain active during heat treatment. At 58°C the
cathepsin B+L activity is increased compared to 48°C and 53°C and at 55°C compared to 25°C,
40°C and 70°C. A prolonged heating time of 17 hours at 58°C has also shown to increase
cathepsin B+L activity. The proteolytic degradation results in the occurrence of peptides
and amino acids such as tryptophan, tyrosine, leucine and histidine which could lead to a
faster degree of satiety when consumed.
According to the aminostatic hypothesis by Mellinkoff, a rise in plasma amino acids elicited
by protein ingestion could assist in the suppression of food intake and the onset of
satiety.
The investigators therefore hypothesize that the ingestion of LTLT cooked pork would induce
a faster satiety response due to the higher availability of peptides and amino acids prior
to digestion. An acute meal study will elucidate this. LTLT cooking will be performed by the
"cook-chill" method to mimic real life where meat is rapidly chilled after heat treatment,
stored at 0-2°C and reheated and browned prior to serving.
Status | Completed |
Enrollment | 40 |
Est. completion date | December 2014 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Participants who have provided written informed consent - Healthy men - Ages between 18 and 60 years - BMI between 18.5 and 30 kg/m2 - Pork eaters Exclusion Criteria: - Any food allergy, dislike or special diet of relevance to the study (e.g. vegetarian) - Daily use of prescription medicine or over-the-counter drugs affecting appetite, energy expenditure or protein metabolism - Use of dietary supplements (including protein supplement, powders, shakes) up to 1 month before the first meal test - Irregular eating schedule (e.g. skipping breakfast) - Self-reporting currently dieting or having lost/gained significant amount of weight (±3 kg) in the previous 3 months - Any known chronic diseases (e.g. cancer, heart disease, diabetes, neurological disorders) - Vigorous physical activity more than 10 hours/week - Smoking, smoking cessation within the past 3 months or nicotine use (electronic cigarettes) (>10 cigarettes per day) - Participants who work in appetite or feeding related areas - Participation in other intervention studies - Participants not able to comply with the study protocol as judged by study personnel |
Country | Name | City | State |
---|---|---|---|
Denmark | Danish Meat Research Institute | Taastrup |
Lead Sponsor | Collaborator |
---|---|
University of Copenhagen | Danish Meat Research Institute |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Ad libitum energy intake | the primary outcome is measured 180 min after test meal is consumed | 180 min | |
Secondary | VAS scores for appetite (hunger, satiety, fullness, prospective consumption) | The secondary endpoints are measured every 30 minute after the test meal is consumed | every 30 min at time points 15, 45, 75, 105, 135, 165, 195 min from termination of the test meal. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05483998 -
A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants
|
Phase 1 | |
Recruiting |
NCT02235012 -
Cognitive Biases Under Ketamine
|
N/A | |
Recruiting |
NCT02417714 -
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
|
||
Completed |
NCT05088343 -
Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04418973 -
Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject.
|
N/A | |
Not yet recruiting |
NCT06248801 -
Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets
|
Phase 1 | |
Terminated |
NCT04068259 -
Single Ascending Dose Study of PBI-4547 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03279302 -
Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects
|
Phase 1 | |
Not yet recruiting |
NCT06233162 -
Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets
|
Phase 1 | |
Recruiting |
NCT04159844 -
Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects
|
N/A | |
Completed |
NCT06137911 -
Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults.
|
Phase 1 | |
Completed |
NCT04849286 -
Measurement of HTL0016878 in Cerebrospinal Fluid
|
Phase 1 | |
Not yet recruiting |
NCT06233227 -
Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule
|
Phase 1 | |
Completed |
NCT04096157 -
A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants
|
Phase 1 | |
Completed |
NCT01200368 -
Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants
|
Phase 3 | |
Recruiting |
NCT05805033 -
Peri-Implant Soft Tissue Integration in Humans: Influence of Material
|
N/A | |
Completed |
NCT04027803 -
Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris®
|
Phase 1 | |
Recruiting |
NCT03467880 -
Multicenter Study of Impulse Oscillometry in Chinese
|
N/A | |
Completed |
NCT02903095 -
Single Ascending Dose Study of TD-1439 in Healthy Subjects
|
Phase 1 | |
Active, not recruiting |
NCT02341508 -
A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers
|
Phase 1 |